European survey of cardiovascular disease prevention and diabetes (EuroAspire) - IV
- Conditions
- 10011082chestpaincoronary heart disease
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 715
- *18 years and < 80
- first or recurrent clinical diagnosis or treatments for coronary heart disease (see below) will be retrospectively identified from diagnostic registers, hospital discharge lists or other sources
- the starting date for identification will be not less than 6 months and not more than 3
years prior to the expected date of interview.
- Patients may fulfil more than one of the following diagnostic criteria:
* Elective or emergency coronary artery by-pass graft (CABG) operation (this includes emergency
CABG for AMI).
* Elective or emergency percutaneous transluminal coronary angioplasty (PCI) (this includes primary
PCI for AMI).
* Acute myocardial infarction (ST elevation and Non ST elevation MI)
* Acute myocardial ischaemia but no evidence of infarction (Troponin negative)
Patients admitted to hospital from outside the geographical area
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>To evaluate the proportions of hospital coronary patients and high risk<br /><br>individuals in primary care achieving European lifestyle, risk factors and<br /><br>therapeutic targets for cardiovascular disease prevention.<br /><br><br /><br>The evaluate the management of risk in terms of lifestyle intervention and the<br /><br>use of drug therapies in relation to the lifestyle and therapeutic goals<br /><br>defined in the Vth European guidelines on cardiovascular disease prevention<br /><br>(2012).</p><br>
- Secondary Outcome Measures
Name Time Method <p>To evaluate cardiovascular events (non-fatal coronary and cardiovascular<br /><br>events, including revascularisation and hospitalisations, and<br /><br>cardiovascular/total mortality)</p><br>